CK3 (vitamin C and vitamin K3) therapy was introduced in 2003 by Verrax, Delveaux, Jamison and others as a “new, non-toxic adjuvant cancer therapy.”
Blog - IVtoGo Blog
"It was just as good as IV Vitamin C - if not better - and it was portable, so I could take it at home or anywhere else."
IVtoGo holds advantages over in IV in destination, biocompatibiity, and duration. These three considerations reveal why and how IVtoGo provides a supremely convenient alternative to traditional IV vitamin C therapy.
Page 2 of 4